308 related articles for article (PubMed ID: 19734355)
1. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
Ngoh GA; Hamid T; Prabhu SD; Jones SP
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
[TBL] [Abstract][Full Text] [Related]
2. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1509-20. PubMed ID: 18367586
[TBL] [Abstract][Full Text] [Related]
3. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
Ngoh GA; Facundo HT; Hamid T; Dillmann W; Zachara NE; Jones SP
Circ Res; 2009 Jan; 104(1):41-9. PubMed ID: 19023128
[TBL] [Abstract][Full Text] [Related]
4. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
5. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.
Champattanachai V; Marchase RB; Chatham JC
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C178-87. PubMed ID: 16899550
[TBL] [Abstract][Full Text] [Related]
6. Augmented O-GlcNAc signaling attenuates oxidative stress and calcium overload in cardiomyocytes.
Ngoh GA; Watson LJ; Facundo HT; Jones SP
Amino Acids; 2011 Mar; 40(3):895-911. PubMed ID: 20798965
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition.
Fu HY; Minamino T; Tsukamoto O; Sawada T; Asai M; Kato H; Asano Y; Fujita M; Takashima S; Hori M; Kitakaze M
Cardiovasc Res; 2008 Sep; 79(4):600-10. PubMed ID: 18508854
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
[TBL] [Abstract][Full Text] [Related]
9. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
10. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
11. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection by N-acetylglucosamine linkage to cellular proteins.
Jones SP; Zachara NE; Ngoh GA; Hill BG; Teshima Y; Bhatnagar A; Hart GW; Marbán E
Circulation; 2008 Mar; 117(9):1172-82. PubMed ID: 18285568
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
[TBL] [Abstract][Full Text] [Related]
15. O-linked beta-N-acetylglucosaminylation in mouse embryonic neural precursor cells.
Yanagisawa M; Yu RK
J Neurosci Res; 2009 Dec; 87(16):3535-45. PubMed ID: 19598243
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
[TBL] [Abstract][Full Text] [Related]
17. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
[TBL] [Abstract][Full Text] [Related]
18. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition.
Ngoh GA; Watson LJ; Facundo HT; Dillmann W; Jones SP
J Mol Cell Cardiol; 2008 Aug; 45(2):313-25. PubMed ID: 18539296
[TBL] [Abstract][Full Text] [Related]
19. Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.
Liu J; Marchase RB; Chatham JC
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1391-9. PubMed ID: 17573462
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine-induced increase in Akt phosphorylation corresponds to increased endoplasmic reticulum stress in astroglial cells.
Matthews JA; Belof JL; Acevedo-Duncan M; Potter RL
Mol Cell Biochem; 2007 Apr; 298(1-2):109-23. PubMed ID: 17136481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
